BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10690578)

  • 1. Defense mechanisms and personality in depression.
    Mullen LS; Blanco C; Vaughan SC; Vaughan R; Roose SP
    Depress Anxiety; 1999; 10(4):168-74. PubMed ID: 10690578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on psychiatric disorders and defensive process assessed by the "defense style questionnaire" in sterile males SAMPLE consulting in andrology].
    Bellone M; Cottencin O; Rigot JM; Goudemand M
    Encephale; 2005; 31(4 Pt 1):414-25. PubMed ID: 16389709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship among three models of personality psychopathology: DSM-III-R personality disorder, TCI scores and DSQ defences.
    Mulder RT; Joyce PR; Sullivan PF; Bulik CM; Carter FA
    Psychol Med; 1999 Jul; 29(4):943-51. PubMed ID: 10473321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term changes in defense styles with psychodynamic psychotherapy for depressive, anxiety, and personality disorders.
    Bond M; Perry JC
    Am J Psychiatry; 2004 Sep; 161(9):1665-71. PubMed ID: 15337658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
    Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
    J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defense styles and Personality dimensions of research subjects with anxiety and depressive disorders.
    Kennedy BL; Schwab JJ; Hyde JA
    Psychiatr Q; 2001; 72(3):251-62. PubMed ID: 11467159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defense mechanisms and personality disorders.
    Lingiardi V; Lonati C; Delucchi F; Fossati A; Vanzulli L; Maffei C
    J Nerv Ment Dis; 1999 Apr; 187(4):224-8. PubMed ID: 10221555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the face validity of the 40 item version of the Defense Style Questionnaire (DSQ-40).
    Chabrol H; Rousseau A; Rodgers R; Callahan S; Pirlot G; Sztulman H
    J Nerv Ment Dis; 2005 Nov; 193(11):756-8. PubMed ID: 16260933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting personality disorder traits with the Defense Style Questionnaire in a normal sample.
    Sinha BK; Watson DC
    J Pers Disord; 1999; 13(3):281-6. PubMed ID: 10498040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergent and discriminant validity of overall defensive functioning.
    Perry JC; Høglend P
    J Nerv Ment Dis; 1998 Sep; 186(9):529-35. PubMed ID: 9741558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defense mechanisms reported by patients with borderline personality disorder and axis II comparison subjects over 16 years of prospective follow-up: description and prediction of recovery.
    Zanarini MC; Frankenburg FR; Fitzmaurice G
    Am J Psychiatry; 2013 Jan; 170(1):111-20. PubMed ID: 23223866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defense mechanisms and Major Depressive Disorder in African American women.
    Porcerelli JH; Olson TR; Presniak MD; Markova T; Miller K
    J Nerv Ment Dis; 2009 Oct; 197(10):736-41. PubMed ID: 19829201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in ego defenses with recovery from depression.
    Akkerman K; Carr V; Lewin T
    J Nerv Ment Dis; 1992 Oct; 180(10):634-8. PubMed ID: 1402841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defense styles, hostility, and psychological risk factors in male patients with personality disorders.
    Paris J; Zweig-Frank H; Bond M; Guzder J
    J Nerv Ment Dis; 1996 Mar; 184(3):153-8. PubMed ID: 8600218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of comorbid personality disorder on the effects of behavioural activation vs. antidepressant medication for major depressive disorder: results from a randomized trial in Iran.
    Moradveisi L; Huibers MJ; Renner F; Arasteh M; Arntz A
    Behav Res Ther; 2013 Aug; 51(8):499-506. PubMed ID: 23792179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent classes of nonresponders, rapid responders, and gradual responders in depressed outpatients receiving antidepressant medication and psychotherapy.
    Thibodeau MA; Quilty LC; De Fruyt F; De Bolle M; Rouillon F; Bagby RM
    Depress Anxiety; 2015 Mar; 32(3):213-20. PubMed ID: 25069431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does personality disorder co-morbidity impact treatment outcome for patients with major depression? A multi-level analysis.
    De Bolle M; De Fruyt F; Quilty LC; Rolland JP; Decuyper M; Bagby RM
    J Pers Disord; 2011 Feb; 25(1):1-15. PubMed ID: 21309619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive personality and treatment outcome in major depressive disorder.
    Ryder AG; Quilty LC; Vachon DD; Bagby RM
    J Pers Disord; 2010 Jun; 24(3):392-404. PubMed ID: 20545502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.